Cite
HARVARD Citation
Das, L. et al. (2017). The value of open access and a patient centric approach to oral oncolytic utilization in the treatment of Chronic Myelogenous Leukemia: A U.S. perspective. Expert review of pharmacoeconomics & outcomes research. pp. 133-140. [Online].